AD-CARE: A Guideline-grounded, Modality-agnostic LLM Agent for Real-world Alzheimer's Disease Diagnosis with Multi-cohort Assessment, Fairness Analysis, and Reader Study

• URL: http://arxiv.org/abs/2603.25322v1
• Date: Thu, 26 Mar 2026 11:10:01 GMT
• Title: AD-CARE: A Guideline-grounded, Modality-agnostic LLM Agent for Real-world Alzheimer's Disease Diagnosis with Multi-cohort Assessment, Fairness Analysis, and Reader Study
• Abstract summary: We introduce AD-CARE, a modality-agnostic agent that performs guideline-grounded diagnostic assessment from incomplete, heterogeneous inputs.<n>By dynamically orchestrating specialized diagnostic tools, AD-CARE generates transparent, report-style outputs aligned with real-world clinical outputs.
• Score: 45.632341143278886
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Alzheimer's disease (AD) is a growing global health challenge as populations age, and timely, accurate diagnosis is essential to reduce individual and societal burden. However, real-world AD assessment is hampered by incomplete, heterogeneous multimodal data and variability across sites and patient demographics. Although large language models (LLMs) have shown promise in biomedicine, their use in AD has largely been confined to answering narrow, disease-specific questions rather than generating comprehensive diagnostic reports that support clinical decision-making. Here we expand LLM capabilities for clinical decision support by introducing AD-CARE, a modality-agnostic agent that performs guideline-grounded diagnostic assessment from incomplete, heterogeneous inputs without imputing missing modalities. By dynamically orchestrating specialized diagnostic tools and embedding clinical guidelines into LLM-driven reasoning, AD-CARE generates transparent, report-style outputs aligned with real-world clinical workflows. Across six cohorts comprising 10,303 cases, AD-CARE achieved 84.9% diagnostic accuracy, delivering 4.2%-13.7% relative improvements over baseline methods. Despite cohort-level differences, dataset-specific accuracies remain robust (80.4%-98.8%), and the agent consistently outperforms all baselines. AD-CARE reduced performance disparities across racial and age subgroups, decreasing the average dispersion of four metrics by 21%-68% and 28%-51%, respectively. In a controlled reader study, the agent improved neurologist and radiologist accuracy by 6%-11% and more than halved decision time. The framework yielded 2.29%-10.66% absolute gains over eight backbone LLMs and converges their performance. These results show that AD-CARE is a scalable, practically deployable framework that can be integrated into routine clinical workflows for multimodal decision support in AD.

Related papers

• ResidencyRL: Reinforcement Learning in Simulated Clinical Environments [53.76751756107077]
  We present ResidencyRL, a reinforcement learning (RL) method for training clinical artificial intelligence (AI) agents through simulated multi-turn clinical encounters.<n>On heldout evaluations, the ResidencyRL agent improves diagnostic accuracy by 7.0% under adversarial conditions.<n>Blinded expert clinicians validated these gains, preferring the trained agent in 87.6% of side-by-side comparisons.
  arXiv  Detail & Related papers  (2026-08-07T17:04:41Z)
• A Proactive Multi-Agent Dialogue Framework for Assessing Social Language Disorder Traits in Autism [11.474807247446526]
  We present TPA (Think, Plan, Ask), a proactive multi-agent dialogue framework applied to the language assessment component of the Autism Diagnostic Observation Schedule Module 4 (ADOS-2)<n>A doctor agent explicitly reasons about which traits remain unobserved before selecting a clinically grounded strategy and generating a targeted question.<n>A patient agent grounded in real ADOS-2 clinical data enables reproducible evaluation without real patient participation, validated across three independent experiments confirming adequate fidelity to real patient language.
  arXiv  Detail & Related papers  (2026-05-21T19:45:46Z)
• Cerebra: A Multidisciplinary AI Board for Multimodal Dementia Characterization and Risk Assessment [56.62016795093786]
  Cerebra is an interactive multi-agent AI team that coordinates specialized agents for EHR, clinical notes, and medical imaging analysis.<n>It supports privacy-preserving deployment by operating on structured representations and remains robust when modalities are incomplete.<n>Cerebra significantly improved expert performance, increasing accuracy by 17.5 percentage points in prospective dementia risk estimation.
  arXiv  Detail & Related papers  (2026-03-23T05:46:45Z)
• Evolving Diagnostic Agents in a Virtual Clinical Environment [75.59389103511559]
  We present a framework for training large language models (LLMs) as diagnostic agents with reinforcement learning.<n>Our method acquires diagnostic strategies through interactive exploration and outcome-based feedback.<n>DiagAgent significantly outperforms 10 state-of-the-art LLMs, including DeepSeek-v3 and GPT-4o.
  arXiv  Detail & Related papers  (2025-10-28T17:19:47Z)
• Timely Clinical Diagnosis through Active Test Selection [49.091903570068155]
  We propose ACTMED (Adaptive Clinical Test selection via Model-based Experimental Design) to better emulate real-world diagnostic reasoning.<n>LLMs act as flexible simulators, generating plausible patient state distributions and supporting belief updates without requiring structured, task-specific training data.<n>We evaluate ACTMED on real-world datasets and show it can optimize test selection to improve diagnostic accuracy, interpretability, and resource use.
  arXiv  Detail & Related papers  (2025-10-21T18:10:45Z)
• MACD: Multi-Agent Clinical Diagnosis with Self-Learned Knowledge for LLM [32.0716204095227]
  Large language models (LLMs) have demonstrated notable potential in medical applications.<n>This study proposes a novel Multi-Agent Clinical Diagnosis (MACD) framework.<n>It allows LLMs to self-learn clinical knowledge via a multi-agent pipeline.
  arXiv  Detail & Related papers  (2025-09-24T12:37:11Z)
• An Agentic System for Rare Disease Diagnosis with Traceable Reasoning [69.46279475491164]
  We introduce DeepRare, the first rare disease diagnosis agentic system powered by a large language model (LLM)<n>DeepRare generates ranked diagnostic hypotheses for rare diseases, each accompanied by a transparent chain of reasoning.<n>The system demonstrates exceptional diagnostic performance among 2,919 diseases, achieving 100% accuracy for 1013 diseases.
  arXiv  Detail & Related papers  (2025-06-25T13:42:26Z)
• Novel Development of LLM Driven mCODE Data Model for Improved Clinical Trial Matching to Enable Standardization and Interoperability in Oncology Research [0.15346678870160887]
  Cancer costs reaching over $208 billion in 2023 alone. Traditional methods regarding clinical trial enrollment and clinical care in oncology are often manual, time-consuming, and lack a data-driven approach. This paper presents a novel framework to streamline standardization, interoperability, and exchange of cancer domains.
  arXiv  Detail & Related papers  (2024-10-18T17:31:35Z)
• Enhancing Diagnostic Accuracy through Multi-Agent Conversations: Using Large Language Models to Mitigate Cognitive Bias [5.421033429862095]
  Cognitive biases in clinical decision-making significantly contribute to errors in diagnosis and suboptimal patient outcomes. This study explores the role of large language models in mitigating these biases through the utilization of a multi-agent framework.
  arXiv  Detail & Related papers  (2024-01-26T01:35:50Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.